Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
DaVita's Ending Cash Position for the quarter that ended in Jun. 2026 was MXN13,119 Mil.
DaVita's quarterly Ending Cash Position
declined
from Dec. 2025 (MXN13,644 Mil) to Mar. 2026 (MXN13,099 Mil) but then
increased
from Mar. 2026 (MXN13,099 Mil) to Jun. 2026 (MXN13,119 Mil).
DaVita's annual Ending Cash Position
increased
from Dec. 2023 (MXN7,887 Mil) to Dec. 2024 (MXN18,349 Mil) but then
declined
from Dec. 2024 (MXN18,349 Mil) to Dec. 2025 (MXN13,644 Mil).
The historical data trend for DaVita's Ending Cash Position can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.
DaVita's Ending Cash Position for the fiscal year that ended in Dec. 2025 is calculated as
What does a Ending Cash Position of MXN13,119 Mil mean?
DaVita (MEX:DVA) has a Ending Cash Position of MXN13,119 Mil as of Jun. 2026. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on DaVita and its competitors.
Is DaVita's Ending Cash Position too high?
DaVita's current Ending Cash Position is MXN13,119 Mil. Overall, DaVita has a GF Score™ of 87/100, reflecting its overall financial health beyond just this single metric.
How does DaVita's Ending Cash Position compare to EHC and THC?
DaVita's Ending Cash Position of MXN13,119 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Ending Cash Position for a Healthcare Providers & Services company?
A good Ending Cash Position depends on the Healthcare Providers & Services industry context. However, Ending Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Ending Cash Position mean?
A high Ending Cash Position can signal that a stock is expensive relative to its fundamentals. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on DaVita and its competitors. DaVita's current Ending Cash Position is MXN13,119 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is DaVita stock overvalued right now?
DaVita (MEX:DVA) has a current Ending Cash Position of MXN13,119 Mil. The stock's GF Value™ is MXN3,611.35, compared to a current price of MXN3,358.09 — trading 7% below its estimated fair value. The current Ending Cash Position is MXN13,119 Mil. DaVita's overall GF Score™ is 87/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Ending Cash Position calculated?
Ending Cash Position is calculated from a company's financial statements. For DaVita (MEX:DVA), the current Ending Cash Position is MXN13,119 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is DaVita (MEX:DVA) Overvalued in 2026?
Based on GuruFocus' analysis, DaVita stock appears to be undervalued.
The current stock price of MXN3,358.09 is trading 7% below its estimated GF Value™ of MXN3,611.35.
Key valuation signals for MEX:DVA:
Ending Cash Position: MXN13,119 Mil
GF Value™: MXN3,611.35 vs. price of MXN3,358.09 (7% below fair value)
No single metric tells the full story. See the MEX:DVA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
DaVita is one of the largest providers of dialysis services in the United States, boasting a market share of about 35%. The firm operates over 3,200 facilities worldwide, mostly in the US, and treats about 300,000 patients annually. Government payers dominate US dialysis reimbursement. DaVita receives about two-thirds of US sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. While commercial insurers represent only about 10% of US patients treated, they represent nearly all of the profits generated by DaVita in the US dialysis business.
87GF Score
Get the complete analysis for MEX:DVA
Ending Cash Position is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:DVA has been successfully added to your 
